TABLE 1 .
Model | Minutes After application | Pig effect p-value | Lobe effect p-value | Baseline effect p-value | Comparison | Odds ratio | 95% lower confidence limit | 95% upper confidence limit |
---|---|---|---|---|---|---|---|---|
Hemostatic effectiveness | 2 | .8997 | .7138 | .0004 | FLOSEAL/SURGIFLO+Thrombin | 0.9249 | 0.1926 | 4.4405 |
– | 5 | .0675 | .2691 | .0023 | FLOSEAL/SURGIFLO+Thrombin | 5.3247 | 1.5950 | 17.7763 |
– | 10 | .0176 | .2100 | .0124 | FLOSEAL/SURGIFLO+Thrombin | 4.9878 | 1.5489 | 16.0616 |
Control of bleeding | 2 | .5099 | .2629 | .0000 | FLOSEAL/SURGIFLO+Thrombin | 1.7315 | 0.4786 | 6.2642 |
– | 5 | .0019 | .0131 | .0001 | FLOSEAL/SURGIFLO+Thrombin | 3.3570 | 1.3394 | 8.4138 |
– | 10 | .0000 | .3001 | .0000 | FLOSEAL/SURGIFLO+Thrombin | 3.8653 | 1.6216 | 9.2135 |